| ₹ crore | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Revenue | 169 | 135 | +24.7% |
| EBITDA | −26.3 | −19.6 | — |
| EBITDA margin | −15.6% | −14.5% | −1.1 pts |
| Profit before tax | −28.4 | −5.2 | — |
| Net profit | 41.6 | −2.8 | — |
| EPS | ₹0.22 | −₹0.02 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast close | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 208 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.1 | 1.1 | 5.7 | 13.8 | 9.6 | ||
| −0.5 | −0.5 | 1.4 | 1.7 | 2.3 | ||
| 105 | 105 | 76.2 | 34.5 | 30.4 | ||
| 312 | — | — | — | — | ||
| 499 | 499 | 480 | 446 | 476 | ||
| — | +4.0% | +7.7% | −6.4% | — | ||
| −48.3 | −48.3 | −21.6 | 4.3 | 11.8 | ||
| −9.7% | −9.7% | −4.5% | 1.0% | 2.5% | ||
| −54.3 | −54.3 | −28.3 | 0.7 | 8.8 | ||
| 18.4 | 18.4 | −10.9 | 13.5 | −15.5 | ||
| 3.7% | 3.7% | −2.3% | 3.0% | −3.3% | ||
| ₹0.10 | ₹0.10 | −₹0.06 | ₹0.08 | −₹0.08 | ||
| — | +268.6% | −177.8% | +191.7% | — | ||
| 310 | 310 | −222 | −41.7 | −110 | ||
| −1.6 | −1.6 | 0.0 | −16.0 | −17.8 | ||
| 308 | 308 | −222 | −57.7 | −128 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 208.3 | |
| - Cash, Equiv & ST Investments | 9.6 | 13.8 | 5.7 | 1.1 | 1.1 | |
| + Minority Interest | 2.3 | 1.7 | 1.4 | -0.5 | -0.5 | |
| + Total Debt | 30.4 | 34.5 | 76.2 | 105.1 | 105.1 | |
| Enterprise Value | — | — | — | — | 311.9 | |
| Revenue | 476.0 | 445.7 | 480.0 | 499.4 | 499.4 | |
| Growth %, YoY | — | -6.4 | +7.7 | +4.0 | — | |
| EBITDA | 11.8 | 4.3 | -21.6 | -48.3 | -48.3 | |
| Margin % | 2.47 | 0.97 | -4.50 | -9.68 | -9.68 | |
| EBIT | 8.8 | 0.7 | -28.3 | -54.3 | -54.3 | |
| Net Income | -15.5 | 13.5 | -10.9 | 18.4 | 18.4 | |
| Margin % | -3.26 | 3.02 | -2.27 | 3.68 | 3.68 | |
| EPS, Adj (current shares) | -0.08 | 0.08 | -0.06 | 0.10 | 0.10 | |
| Growth %, YoY | — | +191.7 | -177.8 | +268.6 | — | |
| Cash from Operations | -110.2 | -41.7 | -222.2 | 309.6 | 309.6 | |
| Capital Expenditures | -17.8 | -16.0 | -0.0 | -1.6 | -1.6 | |
| Free Cash Flow | -128.0 | -57.7 | -222.2 | 308.1 | 308.1 | |
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹18.4 crore on revenue of ₹499 crore. Its debt-to-equity ratio was 0.19 on 31 March 2026. Promoters held 14.20% of the shares on 30 September 2026.
No. Vikas Lifecare had borrowings of ₹105 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.19. Its cash and current investments were ₹1.1 crore, so its net debt was ₹104 crore.
Vikas Lifecare's debt-to-equity ratio was 0.19 on 31 March 2026: borrowings of ₹105 crore against total equity of ₹551 crore. A year earlier, on 31 March 2025, it was 0.14.
Promoters held 14.20% of Vikas Lifecare on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Vikas Lifecare's net worth — shareholders' equity in its consolidated balance sheet — was ₹551 crore on 31 March 2026, up 3.7% from ₹532 crore a year earlier.
Vikas Lifecare's book value per share was ₹2.97 on 31 March 2026: shareholders' equity of ₹551 crore divided by the 185.98 crore shares in issue, up 3.7% from ₹2.86 a year earlier.
Vikas Lifecare's basic earnings per share (EPS) were ₹0.10 in FY26.
In FY26, Vikas Lifecare's return on equity (ROE) was 3.4% and its return on capital employed (ROCE) was −9.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −2.2% and ROCE −5.3%.
On 30 September 2026, Vikas Lifecare's shares were held by promoters 14.20%, foreign portfolio investors (FII/FPI) 0.26%, domestic institutions (DII) 0.00% and retail and other non-institutional investors 85.54%. Over the year, FII holding was down 0.04 percentage points from 0.30% and DII holding was unchanged.
Vikas Lifecare's latest results are for Q4 FY26 (January–March 2026), filed on 22 April 2026: consolidated net profit ₹41.6 crore, against a loss of ₹2.8 crore in Q4 FY25; revenue from operations ₹169 crore, up 24.7% year on year.
In FY26, Vikas Lifecare generated ₹310 crore of cash from operations and spent ₹1.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹308 crore. In FY25 it was −₹222 crore.
In FY26 (April 2025–March 2026), Vikas Lifecare's consolidated net profit was ₹18.4 crore, against a loss of ₹10.9 crore in FY25, on revenue from operations of ₹499 crore (up 4.0%).
In FY26, Vikas Lifecare earned net profit of ₹18.4 crore on revenue of ₹499 crore, against ₹9.5 crore on ₹1,708 crore for Sakuma Exports. Vikas Lifecare's operating margin was −10.9% (Sakuma Exports 0.3%) and its return on equity 3.4% (Sakuma Exports 1.3%).
On FY26 consolidated figures, against Sakuma Exports, Integra Essentia and Kothari Products: Vikas Lifecare's operating margin of −10.9% is the lowest of the four (Sakuma Exports 0.3%, Integra Essentia −0.6%, Kothari Products −5.0%; peer average −1.8%); its return on equity of 3.4% is the highest of the four (Sakuma Exports 1.3%, Integra Essentia 0.2%, Kothari Products 2.7%; peer average 1.4%); its revenue growth over three years of 1.6% a year is the second highest of the four (Sakuma Exports −18.7% a year, Integra Essentia 25.2% a year, Kothari Products −10.0% a year; peer average −1.2% a year).
From Vikas Lifecare's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.